Literature DB >> 15607020

Mechanisms of type-I interferon signal transduction.

Shahab Uddin1, Leonidas C Platanias.   

Abstract

Interferons regulate a number of biological functions including control of cell proliferation, generation of antiviral activities and immumodulation in human cells. Studies by several investigators have identified a number of cellular signaling cascades that are activated during engagement of interferon receptors. The activation of multiple signaling cascades by the interferon receptors appears to be critical for the generation of interferon-mediated biological functions and immune surveillance. The present review summarizes the existing knowledge on the multiple signaling cascades activated by Type I interferons. Recent developments in this research area are emphasized and the implications of these new discoveries on our understanding of interferon actions are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15607020     DOI: 10.5483/bmbrep.2004.37.6.635

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  20 in total

1.  Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2.

Authors:  Barbara Testoni; Christine Völlenkle; Francesca Guerrieri; Sabine Gerbal-Chaloin; Giovanni Blandino; Massimo Levrero
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

Review 2.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

3.  Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.

Authors:  Angela M Hahn; Leslie E Huye; Shunbin Ning; Jennifer Webster-Cyriaque; Joseph S Pagano
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

Authors:  Byron C Burnette; Hua Liang; Youjin Lee; Lukasz Chlewicki; Nikolai N Khodarev; Ralph R Weichselbaum; Yang-Xin Fu; Sogyong L Auh
Journal:  Cancer Res       Date:  2011-02-07       Impact factor: 12.701

5.  Unraveling the complexities of the interferon response during SARS-CoV infection.

Authors:  Anna de Lang; Tracey Baas; Saskia L Smits; Michael G Katze; Albert Dme Osterhaus; Bart L Haagmans
Journal:  Future Virol       Date:  2009-01-01       Impact factor: 1.831

6.  Virus-specific CD4 and CD8 T cell responses in the absence of Th1-associated transcription factors.

Authors:  Sarah B Mollo; Jennifer T Ingram; Robert L Kress; Allan J Zajac; Laurie E Harrington
Journal:  J Leukoc Biol       Date:  2013-11-14       Impact factor: 4.962

7.  Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma.

Authors:  Alex Vasuthasawat; Esther M Yoo; Kham R Trinh; Alan Lichtenstein; John M Timmerman; Sherie L Morrison
Journal:  MAbs       Date:  2016-06-30       Impact factor: 5.857

8.  S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathway.

Authors:  Efthimios Prinarakis; Eleni Chantzoura; Dimitris Thanos; Giannis Spyrou
Journal:  EMBO J       Date:  2008-02-28       Impact factor: 11.598

Review 9.  Immunomodulatory effects of interferons in malignancies.

Authors:  Joseph Bekisz; Yuki Sato; Chase Johnson; Syed R Husain; Raj K Puri; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

10.  Parsing the Interferon Transcriptional Network and Its Disease Associations.

Authors:  Sara Mostafavi; Hideyuki Yoshida; Devapregasan Moodley; Hugo LeBoité; Katherine Rothamel; Towfique Raj; Chun Jimmie Ye; Nicolas Chevrier; Shen-Ying Zhang; Ting Feng; Mark Lee; Jean-Laurent Casanova; James D Clark; Martin Hegen; Jean-Baptiste Telliez; Nir Hacohen; Philip L De Jager; Aviv Regev; Diane Mathis; Christophe Benoist
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.